The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,406.00
Bid: 1,417.00
Ask: 1,419.00
Change: -32.00 (-2.23%)
Spread: 2.00 (0.141%)
Open: 1,432.00
High: 1,448.00
Low: 1,406.00
Prev. Close: 1,438.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 22nd Apr 2021 16:10

Friday 23 April 
Record PLCTrading Statement
XPS Pensions Group PLCTrading Statement
Monday 26 April 
Draper Esprit PLCTrading Statement
International Biotechnology Trust PLCFull Year Results
Pearson PLCQ1 Results
United Oil & Gas PLCFull Year Results
Tuesday 27 April 
Anexo Group PLCFull Year Results
Aveva Group PLCTrading Statement
BP PLCQ1 Results
Egdon Resources PLCHalf Year Results
Focusrite PLCHalf Year Results
Gaming Realms PLCFull Year Results
HSBC Holdings PLCQ1 Results
Inspiration Healthcare Group PLCFull Year Results
IWG PLCQ1 Results
Nostrum Oil & Gas PLCFull Year Results
Property Franchise Group PLCFull Year Results
PZ Cussons PLCQ3 Results
Vivo Energy PLCQ1 Results
Whitbread PLCFull Year Results
Wednesday 28 April 
AB Dynamics PLCHalf Year Results
Brave Bison Group PLCFull Year Results
CRH PLCTrading Statement
French Connection Group PLCFull Year Results
Fresnillo PLCQ1 Production Results
GlaxoSmithKline PLCQ1 Results
HeiQ PLCFull Year Results
Home REIT PLCHalf Year Results
J Sainsbury PLCFull Year Results
Lloyds Banking Group PLCQ1 Results
London Stock Exchange Group PLCTrading Statement
LSL Property Services PLCFull Year Results
Nichols PLCTrading Statement
Pennant International Group PLCFull Year Results
Persimmon PLCTrading Statement
Reckitt Benckiser Group PLCQ1 Results
Renishaw PLCTrading Statement
RPS Group PLCTrading Statement
Tissue Regenix Group PLCFull Year Results
WPP PLCTrading Statement
Yamana Gold IncQ1 Results
Thursday 29 April 
Angle PLCFull Year Results
Appreciate Group PLCTrading Statement
C4X Discovery Holdings PLCHalf Year Results
ConvaTec Group PLCQ1 Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCQ1 Production Results
Howden Joinery Group PLCTrading Statement
Immotion Group PLCTrading Statement
Inchcape PLCQ1 Results
Indivior PLCQ1 Results
international Personal Finance PLCQ1 Results
Kerry Group PLCQ1 Results
Keystone Law Group PLCFull Year Results
Meggitt PLCQ1 Results
NatWest Group PLCQ1 Results
Proactis Holdings PLCHalf Year Results
Royal Dutch Shell PLCQ1 Results
RTW Venture Fund LtdFull Year Results
Schroders PLCQ1 Results
Shield Therapeutics PLCFull Year Results
Smith & Nephew PLCTrading Statement
St James's Place PLCQ1 Results
Standard Chartered PLCQ1 Results
Synthomer PLCQ1 Results
Unilever PLCQ1 Results
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
Xeros Technology Group PLCFull Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Feb 2022 07:49

LONDON MARKET PRE-OPEN: Franchise Brands buys fellow AIM firm Filta

(Alliance News) - Stock prices in London are seen opening slightly higher on Wednesday, adding to strong gains on Tuesday, as tensions on the Russia-Ukraine border appear to have eased.

Read more
16 Feb 2022 07:05

Indivior considers US listing after returning to profit

(Sharecast News) - Indivior said it was considering a US listing for its shares as the drugs company swung to an annual profit and predicted strong growth for its Sublocade opioid.

Read more
9 Feb 2022 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
28 Jan 2022 16:22

UPDATE: Indivior notes robust results for treatment in fentanyl trial

UPDATE: Indivior notes robust results for treatment in fentanyl trial

Read more
28 Jan 2022 14:53

CORRECT: Indivior notes results for painkiller in fentanyl trial

CORRECT: Indivior notes results for painkiller in fentanyl trial

Read more
28 Jan 2022 09:02

Indivior's painkiller demonstrates positive interaction with fentanyl

Indivior's painkiller demonstrates positive interaction with fentanyl

Read more
28 Jan 2022 07:55

Indivior welcomes results from buprenorphine-fentanyl interaction study

(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce respiratory depression and apnea associated with the synthetic opioid fentanyl.

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
10 Nov 2021 12:28

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

Read more
10 Nov 2021 10:12

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

Read more
10 Nov 2021 08:07

Indivior slumps as Scopia Capital sells 20m shares

(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid addiction treatment maker in a placing.

Read more
1 Nov 2021 09:38

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

Read more
28 Oct 2021 13:23

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Read more
28 Oct 2021 12:17

Indivior lifts FY guidance as Q3 profits, revenue jump

(Sharecast News) - Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.

Read more
24 Oct 2021 17:12

Sunday share tips: Light Science Technologies, Indivior

(Sharecast News) - The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.